Harvard Gazette, by Hadley Bridger, Brigham & Women's Hospital ~ August 3, 2015 Skeletal muscle is one of the most abundant tissue types in the human body, but it has proven difficult to produce in large quantities in the lab. Unlike other cell types, such as heart cells, neurons, and cells found in the gut,

Medical News Today, by Catharine Paddock PhD ~ October 27, 2014 A new way to to use stem cells to fight brain cancer is revealed in a proof-of-concept study published in the journal Stem Cells, where scientists describe how they got the cells to produce and release toxins that kill only tumor cells. Led by

ScienceDaily, Source: Harvard University ~ August 6, 2014 A series of studies that begun eight years ago has lead to a report that may be a major step forward in the quest to develop real treatments for amyotrophic lateral sclerosis, ALS, or Lou Gehrig's disease. A series of studies begun by Harvard Stem Cell Institute

Harvard Stem Cell Institute, by Staff ~ June 9, 2014 Harvard Stem Cell Institute (HSCI) scientists collaborating with researchers at the University of Pennsylvania have developed a “genome editing” approach for permanently reducing cholesterol levels in mice with a single injection, potentially reducing heart attack risk by up to 90 percent. “For the first iteration

By Meeri Kim, Published: May 4 The Washington Post The rodent fountain of youth may not be filled with water, but with blood. A trio of new studies has discovered that the blood of young mice appears to reverse some of the effects of aging when put into the circulatory systems of elderly mice. After combining the blood

ScienceDaily, by Staff ~ March 6, 2014 Harvard stem cell scientists have identified a mutation in human cases of acute lymphoblastic leukemia that likely drives relapse. The research, published in Cancer Cell, could translate into improved patient care strategies for this particular blood cancer, which typically affects children but is more deadly in adults. In

Nature, by Chris Palmer Biologists have found a hormone in the liver that spurs the growth of insulin-secreting cells in the pancreas, a discovery they hope will lead to new treatments for diabetes. A team led by Douglas Melton, co-director of the Harvard Stem Cell Institute in Cambridge, Massachusetts, identified the hormone, betatrophin, by inducing